• Galapagos signs agreement to transfer Jyseleca® business to Alfasigma

    Tuesday January 2nd 2024

  • Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

    Thursday December 28th 2023

  • Scientists shed light on what makes human neurons function differently from those of other animals

    Friday December 22nd 2023

  • Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel

    Thursday December 21st 2023

  • Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

    Wednesday December 20th 2023

  • argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus

    Wednesday December 20th 2023

  • Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301

    Wednesday December 20th 2023

  • Biotalys announces results of independent field trials in the U.S.

    Tuesday December 19th 2023

  • Your news here?

  • Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial

    Monday December 18th 2023

  • Belgian researchers find a crack in the wall of WHO’s top priority pathogens

    Thursday December 14th 2023

  • AstriVax awarded €3 million grant to advance therapeutic Hepatitis B vaccine

    Tuesday December 12th 2023


Strategic Partners